Canature Health Technology Co., Ltd. (SHE:300272)
China flag China · Delayed Price · Currency is CNY
5.81
-0.01 (-0.17%)
Sep 4, 2026, 3:04 PM CST

SHE:300272 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,8651,8411,7241,6721,6611,511
Revenue Growth
4.13%6.77%3.14%0.67%9.87%27.97%
Gross Profit
730.04711.46660.01615.87548.75501.96
Operating Income
207.34200.17146.77158.82129.04140.39
Net Income
30.2556.0170.39132.4592.56104.86
Earnings Per Share
0.050.100.120.230.160.18
EPS Growth
-64.25%-21.48%-46.84%41.41%-9.17%260.00%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
East China
386.2387.46363.14324.38291.31
North China
93.5485.57104.692.54121.21
Central China
51.5355.346153.2540.34
South China
75.1977.09109.2596.8195.96
Huaxi
30.9728.06---
Middle East
7.525.893.634.453.92
Europe
297.23283.79244.52261.71265.9
Asia
101.5486.5575.9578.2271.38
North America
771.34690.81660.06698.4571.19
Other
25.923.724.9229.4426.25
Total
1,8411,7241,6721,6611,511

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,0011,113798.14894.88413.1282.02
Total Debt
1,3101,3411,125950.5564.09314.32
Net Cash (Debt)
-308.22-227.32-326.76-55.62-150.99-32.3
Net Cash Growth
------
Net Cash Per Share
-0.51-0.39-0.57-0.10-0.27-0.06

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
305.33299.61292.05374.83155.44186.77
Capital Expenditures
-138.29-144.72-130.86-80.24-94.58-71.29
Free Cash Flow
167.04154.89161.19294.5960.85115.48
Free Cash Flow Growth
2.79%-3.91%-45.28%384.12%-47.30%18.70%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
39.13%38.65%38.28%36.84%33.04%33.21%
Operating Margin
11.11%10.87%8.51%9.50%7.77%9.29%
Pretax Margin
5.27%5.99%7.06%9.50%6.88%9.63%
Profit Margin
1.62%3.04%4.08%7.92%5.57%6.94%
FCF Margin
8.95%8.41%9.35%17.62%3.66%7.64%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1800.1800.1600.1000.1000.100
Dividend Per Share Growth
-47.37%12.50%60.00%0%0%100.00%
Dividend Yield
3.09%2.43%2.69%1.75%2.12%1.57%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
115.9381.6649.3726.2931.8638.89
Forward PE
-35.2435.2435.2435.2435.24
P/FCF Ratio
21.2729.5321.5611.8248.4735.31
PS Ratio
1.902.482.022.081.782.70